Eurand: Phase II/III Clinical Study Compares Safety and Efficacy of Two Doses of ZENPEP(TM) (Pancrelipase) Delayed-Release Capsules for Fat Absorption in Adult Chronic Pancreatitis Patients With Exocrine Pancreatic Insufficiency
11/13/2009 9:57:15 AM
More...
|
Eurand Announces Pricing of Offering of Ordinary Shares
10/22/2009 10:19:15 AM
More...
|
Eurand Announces Proposed Public Offering of Ordinary Shares
10/15/2009 9:27:43 AM
More...
|
Eurand Announces Conference Call on Third Quarter 2009 Financial Results
10/5/2009 11:23:14 AM
More...
|
Eurand Announces Filing of F-3 Registration Statement
9/29/2009 2:40:18 PM
More...
|
Eurand to Present at UBS Global Life Sciences Conference
9/16/2009 10:58:52 AM
More...
|
Eurand Granted FDA Approval for ZENPEP(TM)
8/28/2009 6:35:22 AM
More...
|
Eurand to Participate in Upcoming Investor Conferences
8/19/2009 11:16:15 AM
More...
|
Eurand Reports Recent Developments and Second Quarter 2009 Financial Results
8/6/2009 10:32:18 AM
More...
|
Eurand Successfully Completes Registration Procedure for Paracetamol ODT 250 and 500 mg in the European Union
7/20/2009 11:02:46 AM
More...
|
|